99% Savings - Buy Just @1 Rs X
Kofarest PD Drop, a prescription drug, is manufactured in various forms such as Drops. Secondary and off-label uses of Kofarest PD Drop have also been mentioned below.
The optimal dosage of Kofarest PD Drop is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
The most common side effects of Kofarest PD Drop are Constipation, Heartburn, Nausea or vomiting. While these are the most often observed Kofarest PD Drop side effects, there are can be others also. These have been listed below. These side effects of Kofarest PD Drop are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Kofarest PD Drop's effect is Moderate during pregnancy and Moderate for lactating mothers. In addition, Kofarest PD Drop's effects on the liver, heart and kidney are discussed below in the Kofarest PD Drop related warnings section.
Kofarest PD Drop can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Kofarest PD Drop in conditions like Gastrointestinal Bleeding, Asthma, Smoking Addiction. Some other conditions that can be affected by Kofarest PD Drop are listed in the contraindications section below.
Drug reaction of Kofarest PD Drop with other medicines has been reported. Refer to the list below for further details.
In addition to these precautions, you may also note that Kofarest PD Drop is not safe while driving, and is is not addictive in nature.
Kofarest PD Drop is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Kofarest PD Drop safe for pregnant women?
Pregnant women may experience moderate side effects from Kofarest PD. It is best to stop taking Kofarest PD immediately and inform your doctor if you notice any discomfort.
Is the use of Kofarest PD Drop safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Kofarest PD. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Kofarest PD Drop on the Kidneys?
Kofarest PD may have mild side effects on the kidneys.
What is the effect of Kofarest PD Drop on the Liver?
Kofarest PD is completely safe for the liver.
What is the effect of Kofarest PD Drop on the Heart?
Very few cases of side effects of Kofarest PD on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Kofarest PD Drop unless your doctor advises you to do so -
Is this Kofarest PD Drop habit forming or addictive?
Kofarest PD Drop is not addictive in nature.
Interaction between Food and Kofarest PD Drop
Taking Kofarest PD Drop with food is safe.
Interaction between Alcohol and Kofarest PD Drop
Consult your doctor before consuming alcohol while taking Kofarest PD Drop as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 219
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Guaifenesin
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 629-631
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xopenex® (levalbuterol hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 763-765